Mechanisms of metastasis suppression and translational applications in thyroid cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210647
- Recipient
-
The Ohio State University UEI DLWBSLWAJWR1 Part of The Ohio State University
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $3,874,682
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding
-
- $1,937,341.00 Federal
- $1,937,341.00 Non-federal
- Place of performance
- Columbus, OH 43210, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $3,874,682 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the mechanisms of metastasis suppression and develop translational applications in thyroid cancer. As part of the Military Medical Research and Development program's goal to transform military and public health through innovative biomedical research, this award will support The Ohio State University in conducting basic, applied, and advanced research focused on developing medical solutions for thyroid cancer metastasis on the battlefield and beyond.
Quick answers
Who received award W81XWH2210647?
W81XWH2210647 was awarded to The Ohio State University by Medical Command (Department of the Army) on July 1, 2022.
How much is award W81XWH2210647 worth?
$3,874,682 has been obligated on W81XWH2210647: $1,937,341 in federal funding and $1,937,341 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award